Latest filing published 08 May 2012 for Supernus Pharmaceuticals, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Abingworth Management Ltd has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Solexa, Inc., Xenogen Corp and Supernus Pharmaceuticals, Inc. Over a trading history stretching from 27 January 2005 to 4 May 2012, the count stands at 15 filings.
Every open-market trade on record is a purchase: 1 purchase worth €4.2M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2012: 1 purchase and no sales on the market.
The latest filing, published on 8 May 2012, reports a transaction in Supernus Pharmaceuticals, Inc. The last insider purchase was made public on 8 May 2012, 5,282 days ago. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations